MTOR and acute lymphoblastic leukemia: We have recently shown that the dual PI3K/mTOR inhibitor PKI-587 can inhibit the growth of acute myeloid leukemia (AML) as well as acute lymphoblastic leukemia (ALL) cell lines both in vitro and in vivo [3, 4].